Sophie Lanzkron
Experienced in Sideroblastic Anemia

Dr. Sophie Lanzkron

Hematology
1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
Accepting New Patients
Experienced in Sideroblastic Anemia
1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sophie Lanzkron is a Hematologist in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Experienced provider by MediFind in the treatment of Sideroblastic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is currently accepting new patients.

Her clinical research consists of co-authoring 167 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Albert Einstein College Of Medicine Of Yeshiva University
Residency
University of Maryland Medical Center
Specialties
Hematology
Licenses
Internal Medicine in MD
Board Certifications
Hematology
Fellowships
Johns Hopkins University School of Medicine
Hospital Affiliations
Thomas Jefferson University Hospital
Jefferson Methodist Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Jefferson Hematology - Honickman Center
1101 Chestnut Street, Floor 8, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Lanzkron has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Sickle Cell Disease

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Biological, Other
Study Drug: Red Blood Cell
Study Phase: Phase 3
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizuamb
Study Phase: Phase 2
A Phase 1 Randomized, Double-blind, Placebo-controlled, Multicenter, Ascending Dose, Safety and PK/PD Study of SHP655 (rADAMTS13) in Sickle Cell Disease at Baseline Health
A Phase 1 Randomized, Double-blind, Placebo-controlled, Multicenter, Ascending Dose, Safety and PK/PD Study of SHP655 (rADAMTS13) in Sickle Cell Disease at Baseline Health
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Other, Drug
Study Drug: SHP655
Study Phase: Phase 1
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2
A Phase 2 Study of the Safety and Effectiveness of SANGUINATE™ in the Treatment of Vaso-Occlusive Crises in the Ambulatory Setting: A Placebo-Controlled, Single-Dose, Single-Blind Study in Adults With Sickle Cell Disease
A Phase 2 Study of the Safety and Effectiveness of SANGUINATE™ in the Treatment of Vaso-Occlusive Crises in the Ambulatory Setting: A Placebo-Controlled, Single-Dose, Single-Blind Study in Adults With Sickle Cell Disease
Enrollment Status: Completed
Publish Date: May 23, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

167 Total Publications

Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices.
Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices.
Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025
Similar Doctors
Advanced in Sideroblastic Anemia
Dr. Michael M. Mikhail
Oncology | Hematology
Advanced in Sideroblastic Anemia
Dr. Michael M. Mikhail
Oncology | Hematology

Christiana Care Health Services Inc

4701 Ogletown Stanton Rd, 
Newark, DE 
 (32.8 miles away)
302-623-3605
Languages Spoken:
English
See accepted insurances

Michael Mikhail is an Oncologist and a Hematologist in Newark, Delaware. Dr. Mikhail is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Paget Disease of the Breast, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Thrombocytopenia.

Advanced in Sideroblastic Anemia
Dr. Robert Slease
Hematology
Advanced in Sideroblastic Anemia
Dr. Robert Slease
Hematology
4701 Ogletown Stanton Rd, Ste 4200, 
Newark, DE 
 (32.8 miles away)
302-737-7700
Languages Spoken:
English
See accepted insurances

Robert Slease is a Hematologist in Newark, Delaware. Dr. Slease is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Sezary Syndrome, Sideroblastic Anemia, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Advanced in Sideroblastic Anemia
Dr. Omar Al Ustwani
Hematology | Oncology
Advanced in Sideroblastic Anemia
Dr. Omar Al Ustwani
Hematology | Oncology

Southern Oncology Hematology Assoc

1505 W Sherman Ave, Suite 101, 
Vineland, NJ 
 (35.1 miles away)
856-696-9550
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Omar Al Ustwani is a Hematologist and an Oncologist in Vineland, New Jersey. Dr. Al Ustwani is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Agranulocytosis, Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Al Ustwani is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lanzkron's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile